{"disease":{"id":"lymphocytopenia","name":"lymphocytopenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03158987","title":"Regional Differences in Human Immunodeficiency Virus (HIV) Testing","phase":"","overall_status":"COMPLETED","enrollment_count":999,"lead_sponsor_name":"Jena University Hospital","has_results":false},{"nct_id":"NCT00867269","title":"Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia","phase":"","overall_status":"RECRUITING","enrollment_count":950,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT07202143","title":"Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"YiLin","has_results":false},{"nct_id":"NCT03312244","title":"Pyridostigmine as Immunomodulator in People Living With HIV","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":60,"lead_sponsor_name":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","has_results":false},{"nct_id":"NCT03519464","title":"Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":54,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06584006","title":"Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT02113930","title":"Idiopathic CD4 Lymphocytopenia","phase":"","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02015013","title":"Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04379076","title":"InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Revimmune","has_results":false},{"nct_id":"NCT04407689","title":"InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":34,"lead_sponsor_name":"Revimmune","has_results":false},{"nct_id":"NCT04442178","title":"InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"Revimmune","has_results":false},{"nct_id":"NCT04426201","title":"InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Revimmune","has_results":false},{"nct_id":"NCT04927169","title":"InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Revimmune","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}